Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading on the Nasdaq
February 28, 2022 17:00 ET
|
Cosmos Holdings
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (Nasdaq: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Announces $6 Million Private Placement of Convertible Preferred Stock and Approval to List on the Nasdaq
February 28, 2022 08:30 ET
|
Cosmos Holdings
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Announces Shareholder Approval of Private Offering
December 20, 2021 12:40 ET
|
Cosmos Holdings
CHICAGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021
November 16, 2021 09:15 ET
|
Cosmos Holdings
CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity of CosmoFarm’s Pharmaceutical Logistic Center in Athens, Greece
November 15, 2021 09:11 ET
|
Cosmos Holdings
CHICAGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
UPDATE - Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
September 21, 2021 11:50 ET
|
Cosmos Holdings
CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
September 21, 2021 09:15 ET
|
Cosmos Holdings
CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of...
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
August 18, 2021 09:15 ET
|
Cosmos Holdings
CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic...
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021
August 17, 2021 09:25 ET
|
Cosmos Holdings
CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals,...
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users
August 10, 2021 09:15 ET
|
Cosmos Holdings
CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded pharmaceuticals,...